Skip to main content

COVID-19

Heart Research Institute breakthrough treatment for life-threatening complication of the coronavirus

Read full article

Biography

Dr Clare Arnott is a cardiologist who specialises in advanced cardiac imaging, women’s cardiovascular health and pulmonary hypertension.

Dr Arnott graduated with an MBBS (Hons) from The University of Sydney in 2007. She also holds a Bachelor of Medical Science (2003) and a PhD in Medicine (2017) from The University of Sydney on non-invasive assessment of the heart in pulmonary hypertension and congenital heart disease. She is a fellow of the Royal Australasian College of Physicians.

She completed her basic medical and advanced cardiology training at Royal Prince Alfred Hospital and Prince of Wales Hospital. She also obtained a fellowship in cardiac magnetic resonance imaging at Royal Prince Alfred Hospital.

Dr Arnott is a Staff Specialist cardiologist at Royal Prince Alfred Hospital and established the Women’s Heart Clinic (Charles Perkins Centre) with a particular focus on high risk pregnancies and post-partum cardiovascular health. In addition to this work, she also performs cardiac MRI, cardiac CT at Alfred Imaging (RPA Medical Centre), and is involved in cardiometabolic trials (The George Institute for Global Health).

Dr Arnott is a clinical researcher, with a post-doctoral position at HRI, where she conducts research into pregnancy-associated cardiovascular disease, preeclampsia and pulmonary hypertension. She is regularly invited to speak nationally on her work and has obtained multiple scholarships and awards in the area. Most notably, she has a 2017 Winston Churchill Fellowship for her work in Women’s Cardiovascular Health (Mayo Clinic and Stanford University Hospital) and a Jean Hailes travelling fellowship (2019) for women’s cardiovascular health. Dr Arnott also engages in medical teaching as a Senior Clinical Lecturer at The University of Sydney and Unit of Study co-ordinator for the Masters in Medicine Cardiology Unit.

HRI breakthrough drug for coronavirus

Read full article